News

2015 Jul 23

End-of-Life chemotherapy may do more harm than good

Treating terminally ill cancer patients with chemotherapy in the months or weeks before their deaths was not found to improve patients' quality of life and may actually do more harm than good, according to a new study led by Holly Prigerson, Ph.D. Read more

2015 Jul 16

Karla Ballman named chief of biostatistics and epidemiology

Renowned biostatistician Karla Ballman, Ph.D., has been named chief of the Division of Biostatics and Epidemiology in the Department of Healthcare Policy and Research at Weill Cornell Medical College. Read more

2015 Jul 14

Immune cells recruited to support lung cancer growth

Lung cancers attract circulating immune cells to the tumor mass, where the cancer reprograms them to support its growth and progression, according to a study by Vivek Mittal and colleagues. Read more

2015 Jul 13

Improving the odds for people with Non-Hodgkin Lymphoma

Peter Martin, M.D., is leading Weill Cornell participation in a multi-institutional, $11m NCI study Read more

2015 Jul 10

Targeting copper to treat breast cancer

The promise - and challenges - of copper depletion therapy for triple negative breast cancer. Read more

2015 Jul 07

All aboard: Will molecular tumor boards help cancer patients?

Mark Rubin, M.D., director of the Institute for Precision Medicine, discusses molecular tumor boards. Read more

2015 Jul 07

Varmus returns to his roots in cancer genetics

Harold Varmus, M.D., discusses his career and the future of cancer care in interviews with JAMA and Scientific American. Read more

2015 Jul 07

Absence of tumor-suppressing gene derails DNA replication

If tumor-suppressor gene PTEN has mutated or is absent, the DNA replication process derails and can lead to cancer development, according to a new study by Wen Shen, Ph.D. Read more

2015 Jul 04

Doublets match triplet regimens in transplant-ineligible myeloma

Double-drug therapy may be just as effective as triple-drug therapy, with less toxicity, for some patients with transplant-ineligible multiple myeloma, according to a study by Ruben Niesvizky, M.D. Read more

2015 Jul 02

A new method to diagnose an aggressive prostate cancer subset

Himisha Beltran, M.D., developed an 81-gene classifier that enables diagnosis of the complex and variable neuroendocrine subclass of treatment-resistant prostate cancer. Read more

2015 Jul 01

A new angle: Attacking DIPG

Mark Souweidane, M.D., is on the front lines of research into DIPG, a rare brain tumor that kills 250 children every year in North America. Read more

2015 Jun 30

Changing Treatment Landscape in CLL

The treatment landscape for individuals with chronic lymphocytic leukemia (CLL) has evolved dramatically over the past few years, according to Richard Furman, M.D. Read more

2015 Jun 29

Glimcher among Crain's "Most Powerful Women of 2015"

Dean Laurie Glimcher, M.D., made the list of Crain's New York Business Most Powerful Women 2015. Read more

2015 Jun 25

Promising results for new AML treatment

Gail Roboz, M.D., comments on the results of a phase III study of a new treatment for secondary acute myeloid leukemia (AML) Read more

2015 Jun 23

Tumors' mechanical properties affect protein production

Study into the mechanisms of tissue stiffening prompts discoveries about cellular splicing of key proteins. Read more

2015 Jun 18

At the top: 21 Meyer members make NY Mag list

Many members of the Meyer Cancer Center were among the 1,282 New York area physicians on the New York magazine "Top Doctors" list Read more

2015 Jun 18

A single gene turns colorectal cancer cells back into normal tissue in mice

Cancer cells can be coaxed to turn back into normal tissue simply by reactivating a single gene, according to a paper by Lukas Dow. Read more

Khaoula Mazouzi, M.D., with her IDEA mentor Eleni Andreopoulou, M.D.

2015 Jun 16

A great IDEA: Mentorship program inspires international collaboration

A visit to Weill gave young Algerian doctor Khaoula Mazouzi a glimpse into how multidisciplinary clinical care and translational research is conducted Read more

2015 Jun 15

Two Weill winners of inaugural Breakout Awards

Dilek Colak and Costas Lyssiotis have received prizes as part of the Tri-Institutional Breakout Awards for Junior Investigators Read more

2015 Jun 15

eConsent coming to Weill cancer clinics

The Joint Clinical Trials Office has contracted with a California company to develop an electronic informed consent program for oncology patients at Weill Cornell Medical College and NewYork-Presbyterian Hospital. Read more

News

End-of-Life chemotherapy may do more harm than good

Karla Ballman named chief of biostatistics and epidemiology

Immune cells recruited to support lung cancer growth

Improving the odds for people with Non-Hodgkin Lymphoma

Targeting copper to treat breast cancer

All aboard: Will molecular tumor boards help cancer patients?

Varmus returns to his roots in cancer genetics

Absence of tumor-suppressing gene derails DNA replication

Doublets match triplet regimens in transplant-ineligible myeloma

A new method to diagnose an aggressive prostate cancer subset

A new angle: Attacking DIPG

Changing Treatment Landscape in CLL

Glimcher among Crain's "Most Powerful Women of 2015"

Promising results for new AML treatment

Tumors' mechanical properties affect protein production

At the top: 21 Meyer members make NY Mag list

A single gene turns colorectal cancer cells back into normal tissue in mice

A great IDEA: Mentorship program inspires international collaboration

Two Weill winners of inaugural Breakout Awards

eConsent coming to Weill cancer clinics

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters